DLK1 Antikörper (Extracellular Domain)
Kurzübersicht für DLK1 Antikörper (Extracellular Domain) (ABIN1169189)
Target
Alle DLK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Extracellular Domain
-
Spezifität
- Recognizes human DLK1. Detects a band of ~42 kDa by Western blot.
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Weakly cross-reacts with mouse Dlk1.
-
Sterilität
- 0.2 μm filtered
-
Immunogen
- Recombinant human DLK1 (extracellular domain).
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 6 months after receipt when stored at -20°C. -
Haltbarkeit
- 6 months
-
-
- DLK1 (delta-Like 1 Homolog (Drosophila) (DLK1))
-
Andere Bezeichnung
- DLK1
-
Hintergrund
- The transmembrane and secreted protein delta-like 1 homolog (DLK1, Protein delta homolog 1, Preadipocyte factor 1, Pref-1) belongs to the EGF-like family. It can be cleaved by a tumor necrosis factor-alpha converting enzyme (TACE) to release a soluble form. DLK1 plays important roles in regulating cell differentiation such as adipogenesis and osteogenesis. Membrane-bound DLK1 promotes hypertrophic myotube formation, whereas soluble DLK1 inhibits myotube formation. The soluble form of DLK1 inhibits preadipocyte differentiation, while membrane DLK1 represses preadipocyte proliferation. DLK1 is also associated with tumor invasion.
-
UniProt
- P80370
Target
-